These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9031669)

  • 21. Probing the role of the mycosamine C2'-OH on the activity of amphotericin B.
    Croatt MP; Carreira EM
    Org Lett; 2011 Mar; 13(6):1390-3. PubMed ID: 21322610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformation and position of membrane-bound amphotericin B deduced from NMR in SDS micelles.
    Matsumori N; Houdai T; Murata M
    J Org Chem; 2007 Feb; 72(3):700-6. PubMed ID: 17253784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of amphotericin B amino group basicity in its antifungal action. A theoretical approach.
    Bagiński M; Gariboldi P; Borowski E
    Biophys Chem; 1994 Apr; 49(3):241-50. PubMed ID: 8018821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioactive fluorinated derivative of amphotericin B.
    Matsumori N; Umegawa Y; Oishi T; Murata M
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3565-7. PubMed ID: 15963721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereostructure of Rimocidin.
    Sowiński P; Pawlak J; Borowski E; Gariboldi P
    J Antibiot (Tokyo); 1995 Nov; 48(11):1288-91. PubMed ID: 8557570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synthesis and biological activity of hydrophosphoryl derivatives of amphotericin B].
    Belakhov VV; Shenin IuD; Arabiĭskiĭ RA; Shtil'bans EB
    Antibiot Khimioter; 1996; 41(7-8):4-8. PubMed ID: 8999761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the relative and absolute configuration of the dimethylmyristoyl side chain of pneumocandin B0 by asymmetric synthesis.
    Leonard WR; Belyk KM; Bender DR; Conlon DA; Hughes DL; Reider PJ
    Org Lett; 2002 Nov; 4(24):4201-4. PubMed ID: 12443058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silver Nanoparticles with High Loading Capacity of Amphotericin B: Characterization, Bactericidal and Antifungal Effects.
    Leonhard V; Alasino RV; Munoz A; Beltramo DM
    Curr Drug Deliv; 2018; 15(6):850-859. PubMed ID: 28925873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative theoretical study of the conformations of amphotericin methyl ester and amphotericin B polar heads in the presence of water.
    Meddeb S; Bergès J; Caillet J; Langlet J
    Biochim Biophys Acta; 1992 Dec; 1112(2):266-72. PubMed ID: 1457458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antifungal selectivity of new derivatives of amphotericin B modified at the C-13 position.
    Taylor AW; Costello BJ; Hunter PA; MacLachlan WS; Shanks CT
    J Antibiot (Tokyo); 1993 Mar; 46(3):486-93. PubMed ID: 8478266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simple Strategy for Taming Membrane-Disrupting Antibiotics.
    Yu Y; Sabulski MJ; Schell WA; Pires MM; Perfect JR; Regen SL
    Bioconjug Chem; 2016 Dec; 27(12):2850-2853. PubMed ID: 27801580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of nystatin and amphotericin analogues: characterisation of minor anti-fungal macrolides.
    Ulrych A; Derrick PJ; Adamek F; Novák P; Lemr K; Havlicek V
    Eur J Mass Spectrom (Chichester); 2010; 16(1):73-80. PubMed ID: 20065516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphotericin B. Synthesis of its aglycone (amphoteronolide B) and degradation.
    Masamune S
    Ann N Y Acad Sci; 1988; 544():168-79. PubMed ID: 3214066
    [No Abstract]   [Full Text] [Related]  

  • 34. Precipitation of amphotericin B from i.v. fat emulsion.
    Heide PE
    Am J Health Syst Pharm; 1997 Jun; 54(12):1449. PubMed ID: 9194992
    [No Abstract]   [Full Text] [Related]  

  • 35. The Structure of the Bimolecular Complex between Amphotericin B and Ergosterol in Membranes Is Stabilized by Face-to-Face van der Waals Interaction with Their Rigid Cyclic Cores.
    Nakagawa Y; Umegawa Y; Matsushita N; Yamamoto T; Tsuchikawa H; Hanashima S; Oishi T; Matsumori N; Murata M
    Biochemistry; 2016 Jun; 55(24):3392-402. PubMed ID: 27227740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes.
    Wu W; Wieckowski S; Pastorin G; Benincasa M; Klumpp C; Briand JP; Gennaro R; Prato M; Bianco A
    Angew Chem Int Ed Engl; 2005 Oct; 44(39):6358-62. PubMed ID: 16138384
    [No Abstract]   [Full Text] [Related]  

  • 37. Simultaneous determination of purity and potency of amphotericin B by HPLC.
    Chang Y; Wang YH; Hu CQ
    J Antibiot (Tokyo); 2011 Nov; 64(11):735-9. PubMed ID: 21971300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward understanding of toxic side effects of a polyene antibiotic amphotericin B: fluorescence spectroscopy reveals widespread formation of the specific supramolecular structures of the drug.
    Wasko P; Luchowski R; Tutaj K; Grudzinski W; Adamkiewicz P; Gruszecki WI
    Mol Pharm; 2012 May; 9(5):1511-20. PubMed ID: 22506900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aranochlor A and aranochlor B, two new metabolites from Pseudoarachniotus roseus: production, isolation, structure elucidation and biological properties.
    Mukhopadhyay T; Bhat RG; Roy K; Vijayakumar EK; Ganguli BN
    J Antibiot (Tokyo); 1998 Apr; 51(4):439-41. PubMed ID: 9630868
    [No Abstract]   [Full Text] [Related]  

  • 40. An enantioselective synthesis of the C(33)-C(37) fragment of Amphotericin B.
    Karisalmi K; Rissanen K; Koskinen AM
    Org Biomol Chem; 2003 Sep; 1(18):3193-6. PubMed ID: 14527151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.